EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 364 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $768,968 | -44.4% | 34,222 | -41.3% | 0.11% | -38.6% |
| Q1 2024 | $1,383,435 | +60.3% | 58,299 | +62.1% | 0.18% | +4.8% |
| Q4 2023 | $863,040 | +383.7% | 35,975 | +340.5% | 0.17% | +223.1% |
| Q3 2023 | $178,427 | +118.8% | 8,166 | +91.3% | 0.05% | +108.0% |
| Q2 2023 | $81,561 | -4.3% | 4,268 | -2.8% | 0.02% | -13.8% |
| Q1 2023 | $85,229 | +62.1% | 4,391 | +34.0% | 0.03% | +38.1% |
| Q4 2022 | $52,563 | +11.8% | 3,277 | +8.7% | 0.02% | +5.0% |
| Q3 2022 | $47,000 | – | 3,014 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |